Skip to main navigation Skip to search Skip to main content

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

  • Joseph A. Sparano
  • , Lawrence J. Brandt
  • , Janice P. Dutcher
  • , Jon S. DuBois
  • , Michael B. Atkins

Research output: Contribution to journal › Article › peer-review

Abstract

Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

Original languageEnglish (US)
Pages (from-to)617-618
Number of pages2
JournalAnnals of internal medicine
Volume118
Issue number8
StatePublished - Apr 15 1993

ASJC Scopus subject areas

  • Internal Medicine

Fingerprint

Dive into the research topics of 'Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2'. Together they form a unique fingerprint.

Cite this